Three new ent-kaurane type diterpenes, broussonetones A-C (1-3), were isolated from leaves of Broussonetia papyrifera, together with seven known compounds, and their structures determined by 1D and 2D NMR and MS methods. Compounds 1-3 were marginal inhibitors of tyrosinase. Antioxidant assays showed them also to be inhibitors of xanthine oxidase. The mild inhibition of tyrosinase and significant inhibition of xanthine oxidase suggests that 1-3 could be useful ingredients in the development of skin-protecting cosmetics.
In continual study on the heartwood of Rhamnus nakaharai, a new alaternin-8-O-glucoside, namely 1,2,6,8-tetrahydroxy-3-methylanthraquinone-8-O-β-glucopyranoside (1), together with some known compounds were further isolated and characterised by 1-D, 2-D NMR and other spectral evidences. The free radical scavenging and antityrosinase activities of the isolates, including alaternin (1a), emodin (2a), emodin-8-O-β-glucopyranoside (2), 6-methoxysorigenin-8-O-β-glucopyranoside (3) and 6-methoxysorigenin (3a) were tested. Alaternin (1a) exhibited to be mild DPPH radical scavenger with half as potent as vitamin C, while both alaternin (1a) and emodin-8-O-β-glucopyranoside (2) exhibited stronger SOD-like activity than that of BHA. 6-Methoxysorigenin (3a), a reported potential antioxidant, and its 8-O-glucoside (3) both performed significant inhibitory effect on mushroom tyrosinase with about twice as potent as kojic acid, the positive control.
Ng (2015) Effects of Grifolafrondosa non-polar bioactive components on high-fat diet fed and streptozotocin-induced hyperglycemic mice, Pharmaceutical Biology, 53:5, 705-709, DOI: 10.3109/13880209.2014 In vitro hypoglycemic effects of GF was evaluated enzymatically using a-amylase and a-glucosidase inhibition assays, whereas in vivo study was conducted on high-fat diet fed and streptozotocin (HFD + STZ)-induced hyperglycemic mice. GC-MS was used to determine the chemical profiles of bioactive components.Results: The non-polar fraction of GF exhibited a stronger anti-a-glucosidase activity (IC 50 : 0.0332 mg/ml) than acarbose, but its anti-a-amylase activity (IC 50 : 0.671 mg/ml) was weaker. Oral administration of GF at 600 mg/kg (GF600) significantly lowered the blood glucose, HbA1c, average blood glucose, and serum total cholesterol levels in hyperglycemic mice. Although GF was found to contain mainly oleic acid and linoleic acid, their levels in the fungus were low, suggesting that the effects of GF on HFD + STZ-induced hyperglycemic mice could be due to factors other than these fatty acids. Conclusion: These results conclude that GF possesses anti-a-glucosidase activity, and hypoglycemic effect in HFD + STZ-induced hyperglycemic mice.
Grifola frondosa (GF), a high value medicinal mushroom in China and Japan, is popularly consumed as traditional medicines and health foods, especially for enhancing immune functions. In this study, our aim was to examine the immunomodulatory activities of GF and its bioactive compound ergosterol peroxide (EPO) in lipopolysaccharide (LPS)-induced human monocytic (THP-1) cells. At low concentrations, EPO but not other extracts showed a full protection against LPS-induced cell toxicity. EPO significantly blocked MyD88 and VCAM-1 expression, and cytokine (IL-1β, IL-6 and TNF-α) production in LPS-stimulated cells. It also effectively inhibited NF-κB activation, which was further confirmed with siRNA treatment. These results conclude that EPO may play an important role in the immunomodulatory activity of GF through inhibiting the production of pro-inflammatory mediators and activation of NF-κB signaling pathway.
This study examined the inhibitory effects of Grifola frondosa (GF), a medicinal mushroom popularly consumed in traditional medicine and health food, on digestive enzymes related to type 2 diabetes; chemical profiles and inhibitory kinetics of its bioactive fractions were also analyzed. Results showed that all GF extracts showed weak anti-α-amylase activity; however, strong anti-α-glucosidase activity was noted on GF n-hexane extract (GF-H). Further fractionation confirmed that compared with acarbose (a commercial α-glucosidase inhibitor), the nonpolar fraction of GF possessed a stronger anti-α-glucosidase activity but a weaker anti-α-amylase activity. These activities were not derived from ergosterol and ergosterol peroxide, two major compounds of this fraction. The inhibitory kinetics of GF-H on α-glucosidase was competitive inhibition. GF-H was as good as acarbose in inhibiting the starch digestion in vitro. Oleic acid and linoleic acid could be the major active constituents that have contributed to the potency of GF in inhibiting α-glucosidase activity.
Ultraviolet rays are the main cause
of skin aging. Isoflavone structures
are good anti-ultraviolet natural compounds and have an especially
strong anti-ultraviolet B (UVB) effect. However, the anti-ultraviolet
A (UVA) effect of isoflavones is more controversial. Therefore, this
study aims to discover which isoflavone analogue possesses a strong
anti-ultraviolet A. We found the isoflavonoid intermediate deoxybenzoin-3A
(DOB-3A) to be a similar isoflavone structural compound with strong
anti-ultraviolet A effects. Ultraviolet rays with a wavelength of
350 nm are used to irradiate the fibroblasts of the human skin. Western
blot, flow cytometry, and transmission electron microscope analyses
were used to explore its anti-ultraviolet A mechanism. We established
the results that DOB-3A (1) reduced the death of fibroblasts caused
by ultraviolet A, (2) avoided the damage to the organelles and structures
after UVA irradiation, (3) inhibited the generation of intracellular
reactive oxygen species (ROS) and hydrogen peroxide-induced damage,
and (4) decreased the phosphorylation of mitogen-activated protein
kinases (MAPK) caused by UVA. Based on the above findings, DOB-3A
is a very good anti-ultraviolet A isoflavone-related structure. Because
it is simple to synthesize and has good effects, DOB-3A is a suitable
anti-ultraviolet A product with an isoflavone structure. Moreover,
DOB-3A’s structure provides a reference for the synthesis of
anti-UVA isoflavones.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.